C. Bregengård

Statistics

Publications

Citations

387

H-Index

Active since

1993

Affiliations

Novo Nordisk (Denmark)(Current)

C. Bregengård is an author at Novo Nordisk (Denmark) specializing in endothelial-derived tissue factor pathway inhibitor, cellular pharmacology, and antifibrinolytic agents.

Publications per year

1993–1995

Publications

Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.

Søren K. Moestrup, Shumao Cui, Henrik Vorum et al. · Journal of Clinical Investigation · 1995 · 342 citations · Full text

Medicine, Pharmaceutics, Pharmacology +15

Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins

S. Valentin, Ole Nordfang, C. Bregengård et al. · Blood Coagulation & Fibrinolysis · 1993 · 45 citations

Life Sciences, Biochemistry, Molecular Biology +17

1–2 of 2